| Date Filed | Type | Description |
| 06/08/2023 |
4
| ELMS STEVE (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 8,000 options to buy
@ $1.72, valued at
$13.8k
|
|
| 03/08/2023 |
4
| ELMS STEVE (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.|
Txns:
| Granted 25,815 shares
@ $0
Granted 51,630 options to buy
@ $3.35, valued at
$173k
|
|
| 06/22/2022 |
4
| Aisling Capital IV, LP (10% Owner) has filed a Form 4 on Elevation Oncology, Inc.|
Txns:
| Granted 15,619 options to buy
@ $1.31, valued at
$20.5k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| Aisling Capital IV, LP (10% Owner) has filed a Form 4 on Elevation Oncology, Inc.|
Txns:
| Converted 1,893,232 shares
@ $0
Converted 458,360 shares
@ $0
Bought 187,500 shares
@ $16, valued at
$3M
Converted 8,000,000 preferred shares
@ $0
Converted 1,936,834 preferred shares
@ $0 |
|
| 06/28/2021 |
4
| Aisling Capital IV, LP (10% Owner) has filed a Form 4 on Elevation Oncology, Inc.|
Txns:
| Granted 31,238 options to buy
@ $16, valued at
$499.8k
|
|
| 06/24/2021 |
3
| Aisling Capital IV, LP (10% Owner) has filed a Form 3 on Elevation Oncology, Inc. |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
SC 13G
| ELMS STEVE reports a 5.2% stake in Spruce Biosciences, Inc. |
| 06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2020 |
4
| ELMS STEVE (Director) has filed a Form 4 on Zosano Pharma Corp|
Txns:
| Granted 15,000 options to buy
@ $1.01, valued at
$15.2k
|
|
| 05/01/2020 |
4/A
| ELMS STEVE (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.|
Txns:
| Granted 7,500 shares
@ $0 |
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2019 |
4
| Aisling Capital IV, LP (10% Owner) has filed a Form 4 on Zosano Pharma Corp|
Txns:
| Granted 689,655 shares
@ $1.45, valued at
$1000k
|
|
| 08/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/18/2019 |
4
| ELMS STEVE (10% Owner) has filed a Form 4 on Zosano Pharma Corp|
Txns:
| Granted 1,500 options to buy
@ $2.34, valued at
$3.5k
|
|
| 07/15/2019 |
4
| Aisling Capital IV, LP (10% Owner) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC|
Txns:
| Bought 2,500,000 shares
@ $0.6, valued at
$1.5M
|
|
| 04/12/2019 |
4
| Aisling Capital IV, LP (10% Owner) has filed a Form 4 on Zosano Pharma Corp|
Txns:
| Granted 428,571 shares
@ $3.5, valued at
$1.5M
|
|
| 03/15/2019 |
4
| ELMS STEVE (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.|
Txns:
| Granted 30,000 options to buy
@ $3.89, valued at
$116.7k
|
|
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2019 |
3
| Aisling Capital IV, LP (10% Owner) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 07/12/2018 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 1,400,000 shares
@ $179.43, valued at
$251.2M
|
|
| 06/25/2018 |
4
| ELMS STEVE (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.|
Txns:
| Granted 17,500 options to buy
@ $4.91, valued at
$85.9k
|
|
| 06/14/2018 |
4
| ELMS STEVE (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 8,750 options to buy
@ $180.98, valued at
$1.6M
|
|
| 05/21/2018 |
4
| ELMS STEVE (10% Owner) has filed a Form 4 on Zosano Pharma Corp|
Txns:
| Granted 25,000 options to buy
@ $4.27, valued at
$106.8k
|
|
| 04/12/2018 |
3/A
| Aisling Capital IV, LP (10% Owner) has filed a Form 3/A on Zosano Pharma Corp |
| 04/09/2018 |
3
| Aisling Capital IV, LP (10% Owner) has filed a Form 3 on Zosano Pharma Corp |
| 12/20/2017 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 250,000 shares
@ $80.5, valued at
$20.1M
|
|
|